Metabolic dysfunction-associated steatotic liver disease predicts graft failure in kidney transplant recipients

Clicks: 13
ID: 327131
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #198 of 228 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 228 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction Metabolic dysfunction–associated steatotic liver disease (MASLD) has been established to classify steatotic liver disease more accurately. We investigated the association between MASLD score and long-term kidney transplant outcomes. Methods Kidney transplant recipients who underwent national health screening programs from 2009 to 2017 and with follow-up until 2021 were identified using the Korean National Health Insurance Service data. MASLD was defined based on cardiometabolic criteria and the fatty liver index. Results Among 8 326 kidney transplant recipients, 2 027 (24.3%) had MASLD, 25 (0.3%) had MASLD with increased alcohol intake, and 419 (5.0%) had MASLD with other liver diseases. The incidence rates of graft failure (17.5 vs. 11.3, P < 0.001) and mortality (12.5 vs. 8.9 per 1 000 person-years, P < 0.001) were significantly higher in the MASLD group than in those without steatotic liver disease. After adjusting for demographics, lifestyle, comorbidities, estimated glomerular filtration rate, and proteinuria, the adjusted hazard ratios for graft failure and mortality were 1.23 (95% confidence interval, 1.03–1.46) and 1.03 (95% confidence interval, 0.85–1.25), respectively. Conclusions This study identified MASLD as a significant risk factor for graft failure in kidney transplant recipients, highlighting the need for MASLD screening and management in kidney transplant recipients.
Reference Key
openalex_W7204781726 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kyungho Lee, Yebin Park, Hojin Jeon, Junseok Jeon, Jung Eun Lee, Wooseong Huh, Kyungdo Han, Hye Ryoun Jang
Are you one of these authors? Claim your profile
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag294
URL
https://academic.oup.com/ckj/advance-article-pdf/doi/10.1093/ckj/sfag294/70885299/sfag294.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.